Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7148-7154

  Kobayashi, Hiroyuki ^a,b   Kobayashi, Makiko ^a,b   Utsunomiya, Tokuichiro ^a   Herndon, David N ^b   Pollard, Richard B ^a   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4 RECEPTOR; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; THERMAL INJURY; VIRUS ISOLATION;

ANIMALS; BURNS; CERCOPITHECUS AETHIOPS; DRUG THERAPY, COMBINATION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN-4; SOLUBILITY; SPLEEN; T-LYMPHOCYTES; VERO CELLS;

EID: 0033564667     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Jeschke, M. G., R. E. Barrow, S. E. Wolf, and D. N. Herndon. 1998. Mortality in burned children with acute renal failure. Arch. Surg. 133:752.
2. Nguyen, T. T., D. A. Gilpin, N. A. Meyer, and D. N. Herndon. 1996. Current treatment of severely burned patients. Ann. Surg. 223:14.
3. Stillwell, M., and E. S. Caplan. 1989. The septic multiple-trauma patient. Infect. Dis. Clin. North Am. 3:155.
4. Neely, A. N., F. C. Odds, B. K. Basatia, and I. A. Holder. 1988. Characterization of Candida isolates from pediatric burn patients. J. Clin. Microbiol. 26:1645.
5. Kagan, R. J., S. Naraqi, T. Matsuda, and O. M. Jonasson. 1985. Herpes simplex virus and cytomegalovirus infections in burned patients. J. Trauma 25:40.
6. Scott, P., and S. H. E. Kaufmann. 1991. The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today 12:346.
7. Del Prete, G., and S. Romagnani. 1994. The role of Th1 and Th2 subsets in human infectious diseases. Trends Microbiol. 2:4.
8. Romagnani, S. 1996. Understanding the role of Th1/Th2 cells in infection. Trends Microbiol. 4:470.
9. Mosmann, T. R., and R. L. Coffmann. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
10. Sher, A., R. T. Gazzinelli, I. P. Oswald, M. Clerici, M. Kullberg, E. J. Pearce, J. A. Berzofsky, T. R. Mosmann, S. L. James, H. C. Morse III, and G. M. Shearer. 1992. Role of T-cell-derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:183.
11. Fitch, F. W., M. D. McKisic, D. W. Lancki, and T. F. Gajewski. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29.
12. + contrasuppressor T cells improve the resistance of thermally injured mice infected with herpes simplex virus. J. Leukocyte Biol. 58:159.
13. Suzuki, F., and R. B. Pollard. 1982. Alterations of IFN production in a mouse model of thermal injury. J. Immunol. 129:1806.
14. Suzuki, F., and R. B. Pollard. 1982. Mechanism for suppression of IFN-γ responsiveness in mice after thermal injury. J. Immunol. 129:1811.
15. Faist, E., T. S. Kupper, C. C. Baker, I. H. Chaudry, J. Dwyer, and A. E. Baue. 1986. Depression of cellular immunity after major injury: its association with posttraumatic complications and its reversal with immunomodulation. Arch. Surg. 121:1000.
16. Hansbrough, J. H., R. L. Zapata-Sirvent, and V. M. Peterson. 1987. Immunomodulation following burn injury. Surg. Clin. North Am. 67:69.
17. Decker, D., M. Schondorf, F. Bidlingmaier, A. Hirner, and A. A. von Ruecker. 1996. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 119:316.
18. O'Sullivan, S. T., J. A. Lederer, A. F. Horgan, D. H. L. Chin, J. A. Mannick, and M. L. Rodrick. 1995. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222:428.
19. Barlow, Y. 1994. T lymphocytes and immunosuppression in the burned patient: a review. Burns 20:487.
20. Hullman, C. S., H. Yamamoto, S. deSerres, J. A. Frelinger, and A. A. Meyer. 1997. Early but not late burn wound excision partially restores viral-specific T lymphocyte cytotoxicity. J. Trauma 43:441.
21. + T cells through IL-12 produced by Listeria-induced macrophage. Science 260:547.
22. Ma, X., M. Aste-Amezaga, G. Gri, F. Gerosa, and G. Trinchieri. 1997. Immunomodulatory functions and molecular regulation of IL-12, Chem. Immunol. 68:1.
23. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Popisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of IFN-γ production by NK cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
24. + T cells. J. Immunol. 154:5071.
25. Matsuo, R., M. Kobayashi, D. N. Herndon, R. B. Pollard, and F. Suzuki. 1996. Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J. Leukocyte Biol. 59:623.
26. Jacobs, C. A., D. H. Lynch, E. R. Roux, R. Miller, B. Davis, M. B. Widmer, J. Wignall, T. Vandenbos, L. S. Park, and M. P. Beckmann. 1991. Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptor. Blood 77:2397.
27. Fanslow, W. C., K. N. Clifford, L. S. Park, A. S. Rubin, R. F. Voice, M. P. Beckmann, and M. B. Widmer. 1991. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J. Immunol. 147:535.
28. Puccetti, P., A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, K. H. Enssle, L. Romani, and F. Bistoni. 1994. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis. 169:1325.
29. Gessner, A., K. Schroppel, A. Will, K. H. Enssle, L. Lauffer, and M. Rollinghoff. 1994. Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous leishmaniasis. Infect. Immun. 62:4112.
30. Renz, H., K. Bradley, K. Enssle, J. E. Loader, G. L. Larsen, and E. W. Gelfand. 1996. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int. Arch. Allergy Immunol. 109:167.
31. Takagi, K., F. Suzuki, R. E. Barrow, S. E. Wolf, and D. N. Herndon. 1998. Recombinant human growth hormone modulates ThI and Th2 cytokine response in burned mice. Ann. Surg. 42:635.
32. Kobayashi, M., H. Kobayashi, K. Mon, R. B. Pollard, and F. Suzuki. 1998. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine part 2: mechanism of the antiviral action. Immunol. Cell Biol. 76:209.
33. Ikemoto, K., R. B. Pollard, T. Fukumoto, M. Morimatsu, and F. Suzuki. 1995. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J. Immunol. 155:1326.
34. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
35. Khan, I. A., T. Matsuura, and L. H. Kasper. 1994. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62:1639.
36. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice: reversal by IFN-γ. J. Immunol. 152:1883.
37. Gazzinelli, R. T., N. A. Giese, and H. C. Morse III. 1994. In vitro treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome. J. Exp. Med. 180:2199.
38. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045.
39. Kawakami, K., M. Tohyama, X. Qifeng, and A. Saito. 1997. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effect of interleukin-12. Infect. Immun. 65:1307.
40. Maliszewski, C. R., T. A. Sato, T. V. Bos, S. Waugh, S. K. Dower, J. Slack, M. P. Beckmann, and K. H. Grabstein. 1990. Cytokine receptors and B cell functions: recombinant soluble receptors specifically inhibit IL-1-and IL-4-induced B cell activities in vitro. J. Immunol. 144:3028.
41. + T cells. Eur. J. Immunol. 24:343.
42. Romani, L., A. Mancacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. E. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for Th1 differentiation in murine candidiasis. J. Immunol. 153:5167.
43. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy. 1995. Development commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665.
44. Gerosa, F., C. Paganin, D. Peritt, F. Paiola, M. T. Scupoli, M. Aste-Amezaga, I. Frank, and G. Trinchieri. 1996. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon γ and interleukin-10. J. Exp. Med. 183:2559.
45. Schmitt, E., E. Rude, and T. Germann. 1997. The immunostimulatory function of IL-12 in T-helper cell development and its regulation by TGF-β, IFN-γ, and IL-4. Chem. Immunol. 68:70.
46. 1 mice with chronic cutaneous leishmaniasis. Infect. Immun. 64:5248.